Don't forget guys13 Apr 2013 00:19
This statement in the last RNS
Silence Therapeutics is the only company worldwide who can effectively deliver siRNAs to multiple locations in the human body. Together with the strong patent position in its' synthetic siRNA, AtuRNAi, Silence Therapeutics is amongst a handful of companies who have the freedom to operate in this space.
As a result of the above factors, the company is actively looking at an aggressive expansion of its platform, drug targets and key personnel. The company and its major shareholders are reviewing the financing options in respect of this expansion.
We will have a co with cash of £26M so IMO if the sp drops much further fill yer boots The vibes re sln are sooo much better than for a very long time